MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
172 hedge funds and large institutions have $4.48B invested in Mirati Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 65 increasing their positions, 40 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
51% more capital invested
Capital invested by funds: $2.96B → $4.48B (+$1.52B)
8% more funds holding
Funds holding: 159 → 172 (+13)
Holders
172
Holding in Top 10
13
Calls
$214M
Puts
$108M
Top Buyers
| 1 | +$179M | |
| 2 | +$142M | |
| 3 | +$82.7M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$79.3M |
| 5 |
Renaissance Technologies
New York
|
+$41.1M |
Top Sellers
| 1 | -$173M | |
| 2 | -$41.4M | |
| 3 | -$36.8M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$27.8M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$26.1M |